A Clinical Study of PUVA-Induced Complication in Vitiligo Patients
Young-Sook KIM; Hyung-Chul KANG.
Korean Journal of Dermatology
; : 684-692, 1997.
ArtÃculo en Ko | WPRIM | ID: wpr-88094
Documentos relacionados
Postburn leukoderma successfully treated with topical daylight psoralen UVA therapy.
Use of psoralen therapies obtained abroad in two children with Vitiligo.
A novel mouse model of cutaneous T-cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy.
Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
Psoralen-ultraviolet A endures as one of the most powerful treatments in dermatology: reinforcement of this 'triple-product therapy' by the 2016 British guidelines.
Light- and laser-based treatments for granuloma annulare: A systematic review.
Could psoralen plus ultraviolet A1 ('PUVA1') work? Depth penetration achieved by phototherapy lamps.
A review on PUVA pricks-A debilitating adverse event.
[Combined therapy of psoralen plus ultraviolet A followed by narrow band ultraviolet B photochemotherapy for early stage mycosis fungoides].